| Pharvaris Provides Business Update and Expands Development Program for Deucrictibant | 09/05 06:50 | globenewswire.com |
| Pharvaris Presents Deucrictibant Long-Term Extension Data for Both the Prophylactic and On-Demand Treatment of HAE at the Bradykinin Symposium 2024 | 09/05 06:49 | globenewswire.com |
| Pharvaris Presents Data at the Bradykinin Symposium 2024 | 09/05 06:48 | globenewswire.com |
| Deucrictibant Clinical, Real-World, Nonclinical, and Discovery Data to be Presented at the Bradykinin Symposium | 08/28 06:50 | globenewswire.com |
| Pharvaris Reports Second Quarter 2024 Financial Results and Provides Business Update | 08/14 06:50 | globenewswire.com |
| Pharvaris Announces Annual Meeting of Shareholders | 06/11 06:50 | globenewswire.com |
| Pharvaris Highlights Properties of Deucrictibant in Data Presentations at Recent Congresses | 06/04 06:50 | globenewswire.com |
| Pharvaris to Present Clinical and Nonclinical Data at Upcoming Congresses | 05/13 06:50 | globenewswire.com |
| Pharvaris Reports First Quarter 2024 Financial Results and Provides Business Update | 05/08 16:10 | globenewswire.com |
| Pharvaris Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update | 04/10 16:10 | globenewswire.com |